ContraFect Corporation to Announce First Quarter 2016 Results on May 10, 2016
YONKERS, NY--(Marketwired - May 03, 2016) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW), a clinical-stage biotechnology company focused on the discovery and development of protein therapeutics and antibody products for life-threatening, drug- …